Search

Panacea Biotec

Sector: Healthcare | Industry: Drugs & Pharma
R 210.15 -2.00  | -0.94% 51.40% - 1,284.43
NSE Price: Jul 20, 15:54 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jul 20, 15:54 210.15 -2.00 -0.94% 216.65 212.15 49,895 209.55 - 216.65
BSE Jul 20, 2018 209.70 -1.95 -0.92% 209.45 211.65 6,704 208.95 - 215.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 293,115 P/B: -19.74 NSE Code: PANACEABIO
52-Week Range: R 130.10 - 364.35 Dividend Yield: 0.00% BSE Code: 531349
TTM EPS: R -12.41 Book Value: R -10.62 Face Value: R 1
Price Graph
  • Dishman Carbogen Amcis (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Panacea Biotec -13.52 -19.67 -28.30 51.40 11.71 14.36 -3.75
NIFTY Smallcap 250 Index -22.15 -6.54 -15.50 -9.42 7.49 21.43 10.25
NIFTY Pharma -7.53 -4.26 0.86 -12.28 -12.26 4.20 11.17
Company's return has been calculated on basis of NSE's price.
As on Jul 20, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -16.58 2.23 -5.16
Net Profit -189.83 13.54 11.19
EPS -252.43 12.53 11.02
Book Value -139.50 -191.26 -168.01
Average
Operating Margin 21.13 17.30 5.11
Net Margin -10.25 -9.22 -17.46
Return on Networth 0.00 -84.34 -80.19
Return on Investment 5.21 5.20 1.41
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 10.12 -2.43 -2.43
Operating Profit 6.02 -39.39 -39.39
Net Profit 11.95 60.78 60.78
EPS 11.94 60.78 60.78
TTM
Revenue -0.72 6.60 6.60
Operating Profit -18.31 -19.59 -19.59
Net Profit 15.56 1.07 1.07
EPS 15.56 1.04 1.04
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Panacea Biotec 1,284.43 579.93 -71.88 -12.03 0.00 -19.74 -
Dishman Carbogen Amcis 4,038.08 1,389.11 142.84 10.00 3,676.38 0.79 26.12
Laurus Labs 4,709.31 2,069.00 167.61 7.99 11.97 3.19 28.10
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 28, 2018 Serum Institude Of India Pvt Ltd  Buy Open Market 320,137 267.15 855.25
Mar 13, 2018 Sunanda Jain  Buy Transmission of Shares 5,712,300 284.25 16,237.21
Jul 11, 2016 Nipun Jain  Sell Inter-Se Transfer 300,000 137.35 412.05
Jul 11, 2016 Sunanda Jain  Buy Inter-Se Transfer 300,000 137.35 412.05
Apr 15, 2015 Soshil Kumar Jain (HUF)  Sell Market 9,694 163.80 15.88
Fund Houses invested in the stock
Fund Mar-16 Dec-15 Sep-15 Jun-15 Mar-15
ICICI Prudential Mutual Fund 0.192 0.535 0.539 0.576 0.576
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Panacea Biotec Ltd.

Address: Ambala - Chandigarh Highway, Lalru, Punjab - 140501 | Phone: 01762- 505900 | Fax: 01762- 505909 / 505906

Email: investorgrievances@panaceabiotec.com

Website: www.panacea-biotec.com

Registrar & Transfer Agent: Skyline Financial Services Pvt Ltd

Address: D-153/A, 1st Floor,Okhla Industrial Area, Phase - I, New Delhi - 110020, D-153/A, 1st Floor, Okhla Industrial Area, Phase - I | Phone: 91-011-26812682/84 | Fax: 91-11-26292681

Email: admin@skylinerta.com

comments powered by Disqus
Essential checks
Altman Z-Score
1.09
Piotroski F-Score
4
Modified C-Score
4
5-Years Price to Earnings
Not available
5-Years Price to Book
-19.74
Earnings Yield
EBIT / Enterprise value
2.35%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,424.00 -0.80%
Caplin Point Laboratories R389.30 +0.67%
Dishman Carbogen Amcis R250.90 -2.07%
FDC R227.35 +0.09%
JB Chemicals & Pharma R265.50 +0.19%
Laurus Labs R446.20 -0.22%
Merck R2,261.95 +1.21%
Shilpa Medicare R362.75 -0.93%
Strides Shasun R346.10 +1.14%
Suven Life Sciences R223.80 +3.66%
As on Jul 20, 15:54